Short interest in Enliven Therapeutics Inc (NASDAQ:ELVN) decreased during the last reporting period, falling from 7.07M to 6.91M. This put 33.35% of the company's publicly available shares short.

Short interest for Enliven Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Enliven Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 191.33K shares traded per day, it would take 36.11 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.